title: From outlier to trendsetter.
authors: Soumyadeep
authors: S
authors: Bhaumik
authors: Tamoghna
authors: T
authors: Biswas
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics; D001557:Benzenesulfonates / Q000191:economics; D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics / Q000592:standards*; D004465:Economic Competition; D014943:Global Health; D006801:Humans; D007194:India; D018973:Intellectual Property; D009536:Niacinamide / Q000031:analogs & derivatives; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D010671:Phenylurea Compounds; D011725:Pyridines / Q000191:economics; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D016568:Drugs, Generic; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib